Bhanwra, S., & Ahluwalia, K. (2016). Empagliflozin: the latest SGLT2 inhibitor on the block. International Journal of Basic & Clinical Pharmacology, 5(2), 539–542. https://doi.org/10.18203/2319-2003.ijbcp20160777